Hala Tarek Fathi <br/><br/>
Prame and rhamm genes expression in acute myeloid leukemia /  
  فى حالات اللوكيميا الميلودية الحادةPrame and Rhamm دراسة مدى ظهور جينى  
Hala Tarek Fathi ; Supervised Laila A. M. Hegazy , Asmaa A. Abdelaal , Sara A. Labib 
 - Cairo :   Hala Tarek Fathi ,   2013 
 - 169 P. :   charts , facsimiles ;   25cm 
<br/><br/>Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology 
<br/><br/> Most patients with acute myeloid leukemia who are younger than 60 years achieve complete remission after chemotherapy and / or SCT. However relapse with its high associated morbidity and mortality (5 years survival rate 50% ) still occurs. To improve the clinical outcome of AML patients leukemia associated antigens were suggested to be targets for immune therapies as an additional approach to chemotherapy and / or SCT 
<br/><br/>
<br/><br/><label>Subjects--Index Terms: </label>Acute myeloid leukemia  Prame (preferentially expressed antigen of melanoma Tumor/leukemia associated antigens TAAs/LAAs